EDGAR Filing Documents for 0001193125-17-344271

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-17-344271

Filing Date

2017-11-15

Accepted

2017-11-15 17:20:49

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d492419d424b5.htm	424B5	614526
2	GRAPHIC	g492419g09t98.jpg	GRAPHIC	87579
3	GRAPHIC	g492419g15a09.jpg	GRAPHIC	23181
4	GRAPHIC	g492419g31u05.jpg	GRAPHIC	46685
5	GRAPHIC	g492419g33q34.jpg	GRAPHIC	31748
6	GRAPHIC	g492419g70k55.jpg	GRAPHIC	70838
7	GRAPHIC	g492419g80g84.jpg	GRAPHIC	48247
8	GRAPHIC	g492419g86z17.jpg	GRAPHIC	96301
	Complete submission text file	0001193125-17-344271.txt		1173323

Mailing Address DARWINWEG 24 LEIDEN P7 2333CR

Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000

ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207245 | Film No.: 171206010
SIC: 2834 Pharmaceutical Preparations